New participating site now open:
• Royal Free London
Expanding access to our EU-funded phase III pragmatic trial addressing a key question in 1L mRCC:
IO-IO or IO-TKI?
#clinicalresearch #oncology #RCC #clinicaltrials #care1pct #care1project @ikccorg.bsky.social
New participating site now open:
• Royal Free London
Expanding access to our EU-funded phase III pragmatic trial addressing a key question in 1L mRCC:
IO-IO or IO-TKI?
#clinicalresearch #oncology #RCC #clinicaltrials #care1pct #care1project @ikccorg.bsky.social
@oncoalert.bsky.social
#KidneyCancerAssociation
@actionkidneycancer.bsky.social
@oncoalert.bsky.social
#KidneyCancerAssociation
@actionkidneycancer.bsky.social
New participating sites now open:
• Maastricht UMC+
• Leiden University Medical Center
Expanding access to our EU-funded phase III pragmatic trial tackling a key question in 1L mRCC:
IO-IO or IO-TKI?
#clinicaltrials #oncology #RCC #care1project #care1pct
New participating sites now open:
• Maastricht UMC+
• Leiden University Medical Center
Expanding access to our EU-funded phase III pragmatic trial tackling a key question in 1L mRCC:
IO-IO or IO-TKI?
#clinicaltrials #oncology #RCC #care1project #care1pct
IO-IO or IO-TKI in 1L mRCC?
We still lack biomarkers to guide treatment choice.
👉 CARE1, an EU-funded phase III pragmatic trial, is the only head-to-head randomized study addressing this key question.
#ASCO2026 #clinicaltrials #oncology #care1project #care1pct
IO-IO or IO-TKI in 1L mRCC?
We still lack biomarkers to guide treatment choice.
👉 CARE1, an EU-funded phase III pragmatic trial, is the only head-to-head randomized study addressing this key question.
#ASCO2026 #clinicaltrials #oncology #care1project #care1pct
We are delighted to announce the activation of 7 Belgian sites in the CARE1 pragmatic clinical trial.
#CARE1PCT #CARE1Project #ClinicalTrials #Oncology
We are delighted to announce the activation of 7 Belgian sites in the CARE1 pragmatic clinical trial.
#CARE1PCT #CARE1Project #ClinicalTrials #Oncology
We are pleased to announce the activation of
@LUMC_Leiden
as a participating site in the CARE1 pragmatic clinical trial.
LUMC becomes the 6th active CARE1 site in the Netherlands.
#CARE1PCT #CARE1Project #ClinicalTrials #Oncology
We are pleased to announce the activation of
@LUMC_Leiden
as a participating site in the CARE1 pragmatic clinical trial.
LUMC becomes the 6th active CARE1 site in the Netherlands.
#CARE1PCT #CARE1Project #ClinicalTrials #Oncology
@IstTumori
!
youtu.be/coGlAtGPHAk?... via
@YouTube
@IstTumori
!
youtu.be/coGlAtGPHAk?... via
@YouTube
• LinkedIn: www.linkedin.com/company/care...
• Facebook: www.facebook.com/profile.php?...
• X: x.com: x.com/CARE1project
• Website: care1project.com
• Youtube: www.youtube.com/@CARE1_EU
Looking forward to sharing our journey with the Bluesky community!
• LinkedIn: www.linkedin.com/company/care...
• Facebook: www.facebook.com/profile.php?...
• X: x.com: x.com/CARE1project
• Website: care1project.com
• Youtube: www.youtube.com/@CARE1_EU
Looking forward to sharing our journey with the Bluesky community!